Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A disease-specific antigen is a molecule or molecular structure that is uniquely or predominantly associated with a particular disease state, such as cancer, infection, or autoimmune disorders. The specific identity of the antigen varies depending on the disease in question. These antigens are recognized by the immune system and can serve as targets for diagnostic tests, vaccines, and therapeutic interventions. Ideal properties include: High expression density on diseased versus normal tissue, Homogeneous distribution across all target pathological cells, Minimal presence in vital healthy tissues, and Low rate of shedding from cell surface.
Antibody binding to target antigen, inducing cell death or immune activation; delivery of cytotoxic payload to target cells
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disease-Specific Antigen.